Anne M. Phillips's most recent trade in vTv Therapeutics Inc - Ordinary Shares - Class A was a trade of 6,000 Director stock option (right to buy) done . Disclosure was reported to the exchange on June 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| vTv Therapeutics Inc (Class A) | Anne M. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2026 | 6,000 | 16,860 | - | - | Director stock option (right to buy) | |
| Sagimet Biosciences Inc (Class A) | Anne M. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2026 | 39,567 | 39,567 | - | - | Stock Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Anne M. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 20,174 | 20,174 | - | - | Share Option (Right to Buy) | |
| vTv Therapeutics Inc (Class A) | Anne M. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 4,000 | 10,860 | - | - | Director stock option (right to buy) | |
| Sagimet Biosciences Inc (Class A) | Anne M. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 27,268 | 27,268 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc (Class A) | Anne M. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 113,895 | 113,895 | - | - | Stock Option (Right to Buy) | |
| vTv Therapeutics Inc (Class A) | Anne M. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 2,250 | 6,000 | - | - | Director stock option (right to buy) | |
| vTv Therapeutics Inc (Class A) | Anne M. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 860 | 6,860 | - | - | Director stock option (right to buy) | |
| Trevena Inc | Anne M. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 13,700 | 13,700 | - | - | Stock Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Anne M. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 19,516 | 19,516 | - | - | Share Option (Right to Buy) | |
| vTv Therapeutics Inc (Class A) | Anne M. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 3,750 | 3,750 | - | - | Director stock option (right to buy) | |
| Trevena Inc | Anne M. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 13,700 | 13,700 | - | - | Stock Option (Right to Buy) | |
| Trevena Inc | Anne M. Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |